RBC Capital Markets downgraded Applied Therapeutics Inc (NASDAQ:APLT) stock to "sector perform" from "outperform” citing ...

RBC Capital raised the firm’s price target on Descartes Systems (DSGX) to $133 from $115 and keeps an Outperform rating on the shares. Ahead of Q3 ...

Applied Therapeutics stock (APLT) was down 75% early Friday on news the FDA had declined to approve its drug govorestat, ...

RBC Capital analyst Luca Issi maintained a Hold rating on Moderna (MRNA – Research Report) on November 25 and set a price target of $50.00. The ...

Lower interest rates could prod Canadian banks into a mortgage competition next year as the cost of borrowing drops and ...

RBC Capital analyst Michael Siperco maintained a Hold rating on Equinox Gold (EQX – Research Report) on November 25 and set a price target of C$10.00. The company’s shares closed yesterday at $5.60.

Demand for options protection against an equity market crash is rising, even as a post-election rally takes U.S. stocks to ...

Extendicare Inc. has received a target price upgrade from RBC Capital Markets (Analyst Rank#3), which raised its price target to CAD 11 from CAD 9.50. The revision comes on the back of the company’s ...

USA: Chicago-based private equity firm Wind Point Partners has completed a corporate carveout of locomotive services business ...

As an investment banking associate at RBC Capital Markets, MBA graduate Emmanuel Fadahunsi is helping his clients drive ...

Strategists see falling inflation, resilient economic growth, and rising earnings driving further returns for the S&P 500 in ...